<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chaguza C</submitter><funding>Center for AIDS Research, University of Washington</funding><funding>NCATS NIH HHS</funding><funding>Centers for Disease Control and Prevention</funding><funding>NIAID NIH HHS</funding><funding>Yale New Haven Hospital</funding><funding>University of North Carolina Wilmington</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>UNC</funding><pagination>100943</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9906997</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(2)</volume><pubmed_abstract>The chronic infection hypothesis for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant emergence is increasingly gaining credence following the appearance of Omicron. Here, we investigate intrahost evolution and genetic diversity of lineage B.1.517 during a SARS-CoV-2 chronic infection lasting for 471 days (and still ongoing) with consistently recovered infectious virus and high viral genome copies. During the infection, we find an accelerated virus evolutionary rate translating to 35 nucleotide substitutions per year, approximately 2-fold higher than the global SARS-CoV-2 evolutionary rate. This intrahost evolution results in the emergence and persistence of at least three genetically distinct genotypes, suggesting the establishment of spatially structured viral populations continually reseeding different genotypes into the nasopharynx. Finally, we track the temporal dynamics of genetic diversity to identify advantageous mutations and highlight hallmark changes for chronic infection. Our findings demonstrate that untreated chronic infections accelerate SARS-CoV-2 evolution, providing an opportunity for the emergence of genetically divergent variants.</pubmed_abstract><journal>Cell reports. Medicine</journal><pubmed_title>Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection.</pubmed_title><pmcid>PMC9906997</pmcid><funding_grant_id>75D30120C09570</funding_grant_id><funding_grant_id>P30 AI050410</funding_grant_id><funding_grant_id>R01 AI140970</funding_grant_id><funding_grant_id>P30 CA016086</funding_grant_id><funding_grant_id>R01-AI140970</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>P30-AI050410</funding_grant_id><funding_grant_id>P30-CA016086</funding_grant_id><pubmed_authors>Hill V</pubmed_authors><pubmed_authors>Kerantzas N</pubmed_authors><pubmed_authors>Earnest R</pubmed_authors><pubmed_authors>Pham K</pubmed_authors><pubmed_authors>Breban MI</pubmed_authors><pubmed_authors>Peaper D</pubmed_authors><pubmed_authors>Petrone ME</pubmed_authors><pubmed_authors>Yale SARS-CoV-2 Genomic Surveillance Initiative</pubmed_authors><pubmed_authors>Grubaugh ND</pubmed_authors><pubmed_authors>Vogels CBF</pubmed_authors><pubmed_authors>Pena-Hernandez MA</pubmed_authors><pubmed_authors>Koch TR</pubmed_authors><pubmed_authors>De Kumar B</pubmed_authors><pubmed_authors>Ferguson D</pubmed_authors><pubmed_authors>Billig K</pubmed_authors><pubmed_authors>Landry ML</pubmed_authors><pubmed_authors>Schulz W</pubmed_authors><pubmed_authors>Roberts SC</pubmed_authors><pubmed_authors>Zhou S</pubmed_authors><pubmed_authors>Swanstrom RI</pubmed_authors><pubmed_authors>Ott IM</pubmed_authors><pubmed_authors>Castaldi C</pubmed_authors><pubmed_authors>Kalinch CC</pubmed_authors><pubmed_authors>Chaguza C</pubmed_authors><pubmed_authors>Tikhonova IR</pubmed_authors><pubmed_authors>Hahn AM</pubmed_authors><pubmed_authors>Fauver JR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection.</name><description>The chronic infection hypothesis for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant emergence is increasingly gaining credence following the appearance of Omicron. Here, we investigate intrahost evolution and genetic diversity of lineage B.1.517 during a SARS-CoV-2 chronic infection lasting for 471 days (and still ongoing) with consistently recovered infectious virus and high viral genome copies. During the infection, we find an accelerated virus evolutionary rate translating to 35 nucleotide substitutions per year, approximately 2-fold higher than the global SARS-CoV-2 evolutionary rate. This intrahost evolution results in the emergence and persistence of at least three genetically distinct genotypes, suggesting the establishment of spatially structured viral populations continually reseeding different genotypes into the nasopharynx. Finally, we track the temporal dynamics of genetic diversity to identify advantageous mutations and highlight hallmark changes for chronic infection. Our findings demonstrate that untreated chronic infections accelerate SARS-CoV-2 evolution, providing an opportunity for the emergence of genetically divergent variants.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-06-24T03:08:24.738Z</modification><creation>2025-02-18T23:44:50.889Z</creation></dates><accession>S-EPMC9906997</accession><cross_references><pubmed>36791724</pubmed><doi>10.1016/j.xcrm.2023.100943</doi></cross_references></HashMap>